Fibulin-5 function during tumorigenesis

Future Oncology

Volumn 1, Issue 1, 2005, Pages 23-35

  Albig, Allan R ^a   Schiemann, William P ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Angiogenesis; Cancer; Cell invasion; Epithelial mesenchymal transition; Fibulin 5; Metastasis; Signal transduction

Indexed keywords

FBLN5 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RECOMBINANT PROTEIN; SCLEROPROTEIN;

AMINO ACID SEQUENCE; ANGIOGENESIS; ANIMAL; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; EPITHELIUM CELL; HUMAN; MESODERM; MOLECULAR GENETICS; NEOPLASM; PHYSIOLOGY; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; CELL DIFFERENTIATION; EPITHELIAL CELLS; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MESODERM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MOLECULAR SEQUENCE DATA; NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; RECOMBINANT PROTEINS;

EID: 85047689195     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.1517/14796694.1.1.23     Document Type: Review

References (78)

1. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 100, 57-70 (2000).
2. Schwartz MA, Baron V: Interactions between mitogenic stimuli, or, a thousand and one connections. Curr. Opin. Cell Biol. 11, 197 202 (1999).
3. Timpl R, Sasaki T, Kostka G, Chu ML: Fibulins: A versatile family of extracellular matrix proteins. Nature Rev. Mol. Cell Biol. 4, 479-489 (2003).
4. Argraves WS, Greene LM, Cooley MA, Gallagher WM: Fibulins: Physiological and disease perspectives. EMBO Rep. 4, 1127-1131 (2003).
5. Loeys B, Van Maldergem L, Mortier G et al.: Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa. Hum. Mol. Genet. 11, 2113-2118 (2002).
6. de Schepper S, Loeys B, de Paepe A, Lambert J, Naeyaert, JM: Cutis laxa of the autosomal recessive type in a consanguineous family. Eur. J. Dermatol. 13, 529-533 (2003).
7. Markova, D, Zou, Y, Ringpfeil, F et al.: Genetic heterogeneity of cutis laxa: A heterozygous tandem duplication within the fibulin-5 (FBLN5) gene. Am. J. Hum. Genet. 72, 998-1004 (2003).
8. Stone EM, Braun TA, Russell SR et al.: Missense variations in the fibulin 5 gene and age-related macular degeneration. N. Engl. J. Med. 351, 346-353 (2004).
9. Nakamura T, Lozano PR, Ikeda Y et al.: Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature 415, 171-175 (2002).
10. Yanagisawa H, Davis EC, Starcher BC et al.: Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature 415, 168-171 (2002).
11. Schiemann WP, Blobe GC, Kalume DE, Pandey A, Lodish, HF: Context-specific effects of fibulin-5 (DANCE/EVEC) on cell proliferation, motility, and invasion: Fibulin-5 is induced by TGF-β and affects protein kinase cascades. J. Biol. Chem. 277, 27367-27377 (2002).
12. Albig AR, Schiemann WP: Fibulin-5 antagonizes vascular endothelial growth factor (VEGF) signaling and angiogenic sprouting by endothelial cells. DNA Cell Biol. 23, 367-379 (2004).
13. Chu ML, Tsuda T: Fibulins in development and heritable disease. Birth Defects Res. 72, 25-36 (2004).
14. Nakamura T, Ruiz-Lozano P, Lindner V et al.: DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries. J. Biol. Chem. 274, 22476-22483 (1999).
15. Stenflo J, Stenberg Y, Muranyi A: Calciumbinding EGF-like modules in coagulation proteases: Function of the calcium ion in module interactions. Biochim. Biophys. Acta. 1477, 51-63 (2000).
16. Argraves WS, Dickerson K, Burgess WH, Ruoslahti E: Fibulin, a novel protein that interacts with the fibronectin receptor βsubunit cytoplasmic domain. Cell 58, 623-629 (1989).
17. Kluge M, Mann K, Dziadek M, Timpl R: Characterization of a novel calcium-binding 90-kDa glycoprotein (BM-90) shared by basement membranes and serum. Eur. J. Biochem. 193, 651-659 (1990).
18. Zanetti M, Braghetta P, Sabatelli P et al.: EMILIN-1 deficiency induces elastogenesis and vascular cell defects. Mol. Cell. Biol. 24, 638-650 (2004).
19. Kapetanopoulos A, Fresser F, Millonig G, Shaul Y, Baier G, Utermann G: Direct interaction of the extracellular matrix protein dance with apolipoprotein A mediated by the kringle IV-type 2 domain. Mol. Genet. Genomics 267, 440-446 (2002).
20. Liu X, Zhao Y, Gao J et al.: Elastic fibre homeostasis requires lysyl oxidase-like 1 protein. Nature Genet. 36, 178-182 (2004).
21. Blobe GC, Schiemann WP, Lodish HF: Role of transforming growth factor β in human disease. N. Engl. J. Med. 342, 1350-1358 (2000).
22. Elenbaas B, Weinberg RA: Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp. Cell Res. 264, 169-184 (2001).
23. Kowal RC, Richardson JA, Miano JM, Olson EN: EVEC, a novel epidermal growth factorlike repeat-containing protein upregulated in embryonic and diseased adult vasculature. Circ. Res. 84, 1166-1176 (1999).
24. Watson JD, Oster SK, Shago M, Khosravi F, Penn LZ: Identifying genes regulated in a Mycdependent manner. J. Biol. Chem. 277, 36921-36930 (2002).
25. Guo QM, Malek RL, Kim S et al.: Identification of c-Myc responsive genes using rat cDNA microarray. Cancer Res. 60, 5922-5928 (2000).
26. Kuang PP, Goldstein RH, Liu Y, Rishikof DC, Jean JC, Joyce-Brady M: Coordinate expression of fibulin-5/DANCE and elastin during lung injury repair. Am. J. Physiol. Lung Cell. Mol. Physiol. 285, l1147-l1152 (2003).
27. Ohshima H, Tatemichi M, Sawa T: Chemical basis of inflammation-induced carcinogenesis. Arch. Biochem. Biophys. 417, 3-11 (2003).
28. Lecka-Czernik B, Lumpkin CK Jr, Goldstein S: An overexpressed gene transcript in senescent and quiescent human fibroblasts encoding a novel protein in the epidermal growth factor-like repeat family stimulates DNA synthesis. Mol. Cell. Biol. 15, 120-128 (1995).
29. Twal WO, Czirok A, Hegedus B et al.: Fibulin-1 suppression of fibronectinregulated cell adhesion and motility. J. Cell Sci. 114, 4587-4598 (2001).
30. Hayashido Y, Lucas A, Rougeot C, Godyna S, Argraves WS, Rochefort H: Estradiol and fibulin-1 inhibit motility of human ovarianand breast-cancer cells induced by fibronectin. Int. J. Cancer 75, 654-658 (1998).
31. Qing J, Maher VM, Tran H, Argraves WS, Dunstan RW, McCormick JJ: Suppression of anchorage-independent growth and matrigel invasion and delayed tumor formation by elevated expression of fibulin-1D in human fibrosarcoma-derived cell lines. Oncogene 15, 2159-2168 (1997).
32. Du M, Fan X, Hong E, Chen JJ: Interaction of oncogenic papillomavirus E6 proteins with fibulin-1. Biochem. Biophys. Res. Commun. 296, 962-969 (2002).
33. Greene LM, Twal WO, Duffy MJ et al.: Elevated expression and altered processing of fibulin-1 protein in human breast cancer. Br. J. Cancer 88, 871-878 (2003).
34. Forti S, Scanlan MJ, Invernizzi A et al.: Identification of breast cancer-restricted antigens by antibody screening of SKBR3 cDNA library using a preselected patient's serum. Breast Cancer Res. Treat. 73, 245-256 (2002).
35. Moll F, Katsaros D, Lazennec G et al.: oestrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells. Oncogene 21, 1097-1107 (2002).
36. Roger P, Pujol P, Lucas A, Baldet P, Rochefort H: Increased immunostaining of fibulin-1, an oestrogen-regulated protein in the stroma of human ovarian epithelial tumors. Am. J. Pathol. 153, 1579-1588 (1998).
37. Clinton GM, Rougeot C, Derancourt J et al.: oestrogens increase the expression of fibulin-1, an extracellular matrix protein secreted by human ovarian cancer cells. Proc. Natl Acad. Sci. USA 93, 316-320 (1996).
38. Ramaswamy S, Ross KN, Lander ES, Golub TR: A molecular signature of metastasis in primary solid tumors. Nature Genet. 33, 49-54 (2003).
39. Gallagher WM, Greene LM, Ryan MP et al.: Human fibulin-4: Analysis of its biosynthetic processing and mRNA expression in normal and tumor tissues. FEBS Lett. 489, 59-66 (2001).
40. Gallagher WM, Argentini M, Sierra V, Bracco L, Debussche L, Conseiller E: MBP1: A novel mutant p53-specific protein partner with oncogenic properties. Oncogene 18, 3608-3616 (1999).
41. Hood JD, Cheresh DA: Role of integrins in cell invasion and migration. Nature Rev. Cancer 2, 91-100 (2002).
42. Mizejewski GJ: Role of integrins in cancer: Survey of expression patterns. Proc. Soc. Exp. Biol. Med. 222, 124-138 (1999).
43. Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nature Med. 6, 389-395 (2000).
44. Carmeliet P, Jain RK: Angiogenesis in cancer and other diseases. Nature 407, 249-257 (2000).
45. Kerbel R, Folkman J: Clinical translation of angiogenesis inhibitors. Nature Rev. Cancer 2, 727-739 (2002).
46. Hogan BL, Kolodziej PA: Organogenesis: Molecular mechanisms of tubulogenesis. Nat. Rev. Genet. 3, 513-523 (2002).
47. Fidler IJ: The organ microenvironment and cancer metastasis. Differentiation 70, 498-505 (2002).
48. Yoshida BA, Sokoloff MM, Welch DR, Rinker-Schaeffer CW: Metastasis-suppressor genes: A review and perspective on an emerging field. J. Natl Cancer Inst. 92, 1717-1730 (2000).
49. Kostka G, Giltay R, Bloch W et al.: Perinatal lethality and endothelial cell abnormalities in several vessel compartments of fibulin-1-deficient mice. Mol. Cell. Biol. 21, 7025-7034 (2001).
50. Jean JC, Eruchalu I, Cao YX, Joyce-Brady M: DANCE in developing and injured lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 282, L75-L82 (2002).
51. Folkman J, Shing Y: Angiogenesis. J. Biol. Chem. 267, 10931-10934 (1992).
52. Terman BI, Dougher-Vermazen M: Biological properties of VEGF/VPF receptors. Cancer Metastasis Rev. 15, 159-163 (1996).
53. Rousseau S, Houle F, Landry J, Huot, J: p38 map kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15, 2169-2177 (1997).
54. Good DJ, Polverini PJ, Rastinejad F et al.: A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl Acad. Sci. USA 87, 6624-6628 (1990).
55. Bornstein P: Thrombospondins as matricellular modulators of cell function. J. Clin. Invest. 107, 929-934 (2001).
56. Guo N, Krutzsch HC, Inman JK, Roberts DD: Thrombospondin 1 and Type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Cancer Res. 57, 1735-1742 (1997).
57. Rodriguez-Manzaneque JC, Lane TF, Ortega MA, Hynes RO, Lawler J, Iruela-Arispe ML: Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc. Natl Acad. Sci. USA 98, 12485-12490 (2001).
58. Thiery JP: Epithelial-mesenchymal transitions in tumor progression. Nature Rev. Cancer 2, 442-454 (2002).
59. Grunert S, Jechlinger M, Beug H: Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nature Rev. Mol. Cell Biol. 4, 657-665 (2003).
60. Zhang HY, Chu ML, Pan TC, Sasaki T, Timpl R, Ekblom P: Extracellular matrix protein fibulin-2 is expressed in the embryonic endocardial cushion tissue and is a prominent component of valves in adult heart. Dev. Biol. 167, 18-26 (1995).
61. Zhang HY, Timpl R, Sasaki T, Chu ML, Ekblom P: Fibulin-1 and fibulin-2 expression during organogenesis in the developing mouse embryo. Dev. Dyn. 205, 348-364 (1996).
62. Miosge N, Gotz W, Sasaki T, Chu ML, Timpl R, Herken R: The extracellular matrix proteins fibulin-1 and fibulin-2 in the early human embryo. Histochem. J. 28, 109-116 (1996).
63. Spence SG, Argraves WS, Walters L, Hungerford JE, Little CD: Fibulin is localized at sites of epithelial-esenchymal transitions in the early avian embryo. Dev. Biol. 151, 473-484 (1992).
64. Bouchey D, Argraves WS, Little CD: Fibulin-1, vitronectin, and fibronectin expression during avian cardiac valve and septa development. Anat. Rec. 244, 540-551 (1996).
65. Tsuda T, Wang H, Timpl R, Chu ML: Fibulin-2 expression marks transformed mesenchymal cells in developing cardiac valves, aortic arch vessels, and coronary vessels. Dev. Dyn. 222, 89-100 (2001).
66. Blagosklonny MV: Tissue-selective therapy of cancer. Br. J. Cancer 89, 1147-1151 (2003).
67. Dvorak HF: Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650-1659 (1986).
68. Lee MJ, Roy NK, Mogford JE, Schiemann WP, Mustoe TA: Fibulin-5 promotes wound healing in vivo. J. Am. Coll. Surg. 199, 403-410 (2004).
69. Downing AK, Knott V, Werner JM, Cardy CM, Campbell ID, Handford PA: Solution structure of a pair of calcium-binding epidermal growth factor-like domains: Implications for the Marfan Syndrome and other genetic disorders. Cell 85, 597-605 (1996).
70. Debeer P, Schoenmakers EF, Twal WO et al.: The fibulin-1 gene (FBLN1) is disrupted in a t(12;22) associated with a complex type of synpolydactyly. J. Med. Genet. 39, 98-104 (2002).
71. Toren A, Rozenfeld-Granot G, Heath KE et al.: MYH9 spectrum of autosomaldominant giant platelet syndromes: Unexpected association with fibulin-1 variant-D inactivation. Am. J. Hematol. 74, 254-262 (2003).
72. Argraves WS, Tran H, Burgess WH, Dickerson K: Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure. J. Cell Biol. 111, 3155-3164 (1990).
73. Pupa SM, Argraves SW, Forti S et al.: Immunological and pathobiological roles of fibulin-1 in breast cancer. Oncogene 23, 2153-2160 (2004).
74. Pan TC, Sasaki T, Zhang RZ, Fassler R, Timpl R, Chu ML: Structure and expression of fibulin-2, a novel extracellular matrix protein with multiple EGF-like repeats and consensus motifs for calcium binding. J. Cell Biol. 123, 1269-1277 (1993).
75. Giltay R, Timpl R, Kostka G: Sequence, recombinant expression and tissue localization of two novel extracellular matrix proteins, fibulin-3 and fibulin-4. Matrix Biol. 18, 469-480 (1999).
76. Stone EM, Lotery AJ, Munier FL et al.: A single EFEMP1 mutation associated with both malattia leventinese and doyne honeycomb retinal dystrophy. Nature Genet. 22, 199-202 (1999).
77. Marmorstein LY, Munier FL, Arsenijevic Y et al.: Aberrant accumulation of EFEMP1 underlies drusen formation in malattia leventinese and age-related macular degeneration. Proc, Natl Acad. Sci. USA 99, 13067-13072 (2002).
78. Tsuruga E, Yajima T, Irie K: Induction of fibulin-5 gene is regulated by tropoelastin gene, and correlated with tropoelastin accumulation in vitro. Int. J. Biochem. Cell Biol. 36, 395-400 (2004).